Repurposing Antidiabetic Drugs for Cardiovascular Disease.

GLP1 receptor agonist SGLT2 inhibitor cardiovascular outcome trials dipeptidyl peptidase-4 inhibitor drug repurposing metformin

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2020
Historique:
received: 01 06 2020
accepted: 25 08 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 13 10 2020
Statut: epublish

Résumé

Metabolic diseases and diabetes represent an increasing global challenge for human health care. As associated with a strongly elevated risk of developing atherosclerosis, kidney failure and death from myocardial infarction or stroke, the treatment of diabetes requires a more effective approach than lowering blood glucose levels. This review summarizes the evidence for the cardioprotective benefits induced by antidiabetic agents, including sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP1-RA), along with sometimes conversely discussed effects of dipeptidyl peptidase-4 inhibitor (DPP4i) and metformin in patients with high cardiovascular risk with or without type 2 diabetes. Moreover, the proposed mechanisms of the different drugs are described based on the results of preclinical studies. Recent cardiovascular outcome trials unexpectedly confirmed a beneficial effect of GLP-1RA and SGLT2i in type 2 diabetes patients with high cardiovascular risk and with standard care, which was independent of glycaemic control. These results triggered a plethora of studies to clarify the underlying mechanisms and the relevance of these effects. Taken together, the available data strongly highlight the potential of repurposing the original antidiabetics GLP1-RA and SGLT2i to improve cardiovascular outcome even in non-diabetic patients with cardiovascular diseases.

Identifiants

pubmed: 33041865
doi: 10.3389/fphys.2020.568632
pmc: PMC7522553
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

568632

Informations de copyright

Copyright © 2020 Schubert, Hansen, Leefmann and Guan.

Références

Lancet Diabetes Endocrinol. 2015 Aug;3(8):615-23
pubmed: 26179504
Int J Cardiol. 2017 Aug 15;241:379-386
pubmed: 28377185
N Engl J Med. 2019 Aug 29;381(9):841-851
pubmed: 31185157
Mol Nutr Food Res. 2016 Apr;60(4):922-34
pubmed: 26773306
Trends Endocrinol Metab. 2019 Oct;30(10):745-755
pubmed: 31405774
Diabetes Obes Metab. 2017 Sep;19(9):1276-1288
pubmed: 28345814
Diabetes Care. 2004 Jul;27(7):1791-3
pubmed: 15220268
Clin Exp Pharmacol Physiol. 2008 Aug;35(8):895-903
pubmed: 18346173
Am J Cardiol. 2019 Dec 15;124 Suppl 1:S36-S44
pubmed: 31741439
Front Physiol. 2018 Nov 14;9:1622
pubmed: 30487758
Circulation. 2019 Nov 19;140(21):1703-1705
pubmed: 31738593
ESC Heart Fail. 2018 Aug;5(4):642-648
pubmed: 30117720
BMJ. 2016 Jan 08;352:h6748
pubmed: 26747716
Eur J Endocrinol. 2019 Dec;181(6):R211-R234
pubmed: 31600725
Lancet. 2019 Jan 5;393(10166):31-39
pubmed: 30424892
J Clin Invest. 2015 Jan;125(1):14-24
pubmed: 25654546
Diabetes Care. 2013 May;36(5):1304-11
pubmed: 23230096
Front Endocrinol (Lausanne). 2018 Nov 23;9:672
pubmed: 30532733
N Engl J Med. 2013 Oct 3;369(14):1327-35
pubmed: 23992602
Nat Commun. 2013;4:2192
pubmed: 23900241
Lancet Diabetes Endocrinol. 2014 Feb;2(2):116-24
pubmed: 24622715
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Acta Diabetol. 2019 Sep;56(9):1051-1060
pubmed: 30993527
Lancet. 2015 May 23;385(9982):2067-76
pubmed: 25765696
Cardiology. 2020;145(5):311-320
pubmed: 31865310
Am Heart J. 2015 Nov;170(5):845-54
pubmed: 26542491
Circulation. 2019 Apr 23;139(17):2022-2031
pubmed: 30786725
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Lancet. 2018 Oct 27;392(10157):1519-1529
pubmed: 30291013
Lancet Diabetes Endocrinol. 2019 Feb;7(2):89-90
pubmed: 30683221
Int J Cardiol. 2016 Oct 1;220:809-14
pubmed: 27394978
Eur J Heart Fail. 2020 Apr;22(4):618-628
pubmed: 32037659
Circ Res. 2018 Jul 20;123(3):342-355
pubmed: 29760016
Gerontology. 2019;65(6):581-590
pubmed: 31522175
EuroIntervention. 2016 Jul 20;12(4):449-55
pubmed: 27436599
Eur J Heart Fail. 2017 Jan;19(1):69-77
pubmed: 27790809
Lancet. 2015 Oct 10;386(10002):1443-4
pubmed: 26466041
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Diabetes. 2013 Apr;62(4):1270-81
pubmed: 23223177
Clin Kidney J. 2018 Dec;11(6):749-761
pubmed: 30524708
Clin Res Cardiol. 2017 Dec;106(12):939-946
pubmed: 28755285
Eur Heart J. 2019 Nov 1;40(41):3409-3417
pubmed: 30993313
Basic Res Cardiol. 2019 Aug 6;114(5):35
pubmed: 31388770
Expert Rev Cardiovasc Ther. 2015;13(7):753-67
pubmed: 26106933
Medicine (Baltimore). 2019 Nov;98(46):e17860
pubmed: 31725627
Lancet Diabetes Endocrinol. 2014 Feb;2(2):94-5
pubmed: 24622700
Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):18-23
pubmed: 31646274
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Circulation. 2014 Oct 28;130(18):1579-88
pubmed: 25189213
N Engl J Med. 2013 Oct 3;369(14):1317-26
pubmed: 23992601
JAMA. 2016 Aug 2;316(5):500-8
pubmed: 27483064
Circ Res. 2009 Feb 13;104(3):403-11
pubmed: 19096023
Diabetes Obes Metab. 2020 Jun 1;:
pubmed: 32476254
Diabetologia. 2012 Aug;55(8):2154-62
pubmed: 22618812
Diabetologia. 2018 Mar;61(3):722-726
pubmed: 29197997
Lancet. 2019 Jan 5;393(10166):3-5
pubmed: 30424891
Circ Cardiovasc Imaging. 2016 Dec;9(12):
pubmed: 27940956
Eur J Pharm Sci. 2017 Jun 15;104:31-41
pubmed: 28323117
Diabetes Metab Syndr Obes. 2013 Apr 24;6:161-70
pubmed: 23650450
Endocrine. 2016 Jun;52(3):516-26
pubmed: 26573925
Cell Metab. 2018 Apr 3;27(4):740-756
pubmed: 29617641
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
Mol Metab. 2014 May 09;3(5):507-17
pubmed: 25061556
Diabetologia. 2019 Apr;62(4):726-729
pubmed: 30694352
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Eur Heart J. 2019 Nov 1;40(41):3418-3420
pubmed: 31289825
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
JAMA. 2014 Apr 16;311(15):1526-35
pubmed: 24687169
Diabetologia. 2017 Sep;60(9):1620-1629
pubmed: 28770324
Mol Med Rep. 2014 Apr;9(4):1254-8
pubmed: 24535553
Circulation. 2019 May 28;139(22):2591-2593
pubmed: 30882240
J Am Heart Assoc. 2020 May 5;9(9):e015716
pubmed: 32326806
Eur J Heart Fail. 2013 Feb;15(2):185-93
pubmed: 23099356
Curr Diab Rep. 2018 Jul 14;18(9):64
pubmed: 30008022
Cardiovasc Diabetol. 2017 Jan 13;16(1):9
pubmed: 28086951
Diabetologia. 2017 Mar;60(3):568-573
pubmed: 27752710
Cell Metab. 2016 Oct 11;24(4):521-522
pubmed: 27732831
Circulation. 2013 Jan 1;127(1):74-85
pubmed: 23186644
Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609
pubmed: 28615149
JAMA. 2019 Jan 1;321(1):69-79
pubmed: 30418475
Oxid Med Cell Longev. 2018 Apr 19;2018:5396806
pubmed: 29849901
Lancet Diabetes Endocrinol. 2019 Oct;7(10):776-785
pubmed: 31422062
Cardiovasc Drugs Ther. 2017 Apr;31(2):119-132
pubmed: 28447181
Cardiovasc Diabetol. 2018 Jan 11;17(1):12
pubmed: 29325553
Health Technol Assess. 2018 Apr;22(18):1-64
pubmed: 29652246
Physiol Rep. 2018 Jun;6(12):e13741
pubmed: 29932506
Kardiol Pol. 2018;76(9):1336-1343
pubmed: 29862487
Lancet. 2019 Jul 13;394(10193):121-130
pubmed: 31189511
Phytomedicine. 2019 May;58:152745
pubmed: 31005715
Diabetes Obes Metab. 2011 Apr;13(4):366-73
pubmed: 21226820
Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):275-285
pubmed: 30822172
J Mol Endocrinol. 2015 Dec;55(3):245-62
pubmed: 26386043
Int J Environ Res Public Health. 2019 Jul 30;16(15):
pubmed: 31366085
Front Endocrinol (Lausanne). 2019 Jun 19;10:389
pubmed: 31275246
Diabetes Obes Metab. 2013 Jan;15(1):15-27
pubmed: 22776039
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
N Engl J Med. 2006 Jul 20;355(3):260-9
pubmed: 16855266
Circ Heart Fail. 2013 Sep 1;6(5):1029-38
pubmed: 23894014
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Circ Heart Fail. 2013 May;6(3):395-402
pubmed: 23508758
Front Physiol. 2017 Dec 19;8:1077
pubmed: 29311992
Diabetologia. 2019 Mar;62(3):357-369
pubmed: 30607467
J Diabetes. 2016 Jan;8(1):63-75
pubmed: 25565455
Circulation. 2018 Jan 30;137(5):422-424
pubmed: 29378754
Diabetes Obes Metab. 2014 Jul;16(7):588-601
pubmed: 24373190
Hypertension. 2017 Jul;70(1):103-110
pubmed: 28559400
Cardiovasc Drugs Ther. 2018 Dec;32(6):541-552
pubmed: 30328028
N Engl J Med. 2015 Dec 3;373(23):2247-57
pubmed: 26630143
Lancet. 2009 Jun 20;373(9681):2125-35
pubmed: 19501900
Diabetes. 2008 Mar;57(3):696-705
pubmed: 18083782
J Diabetes Investig. 2020 Jan;11(1):39-51
pubmed: 31199578
Lancet Diabetes Endocrinol. 2017 May;5(5):333-340
pubmed: 28330649
Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1120-33
pubmed: 25128166
N Engl J Med. 2017 Sep 28;377(13):1228-1239
pubmed: 28910237
Diabetes. 2009 Apr;58(4):975-83
pubmed: 19151200
Front Physiol. 2020 May 19;11:425
pubmed: 32508669
Circulation. 2019 May 28;139(22):2528-2536
pubmed: 30882238
Diabetes. 2014 Jul;63(7):2394-401
pubmed: 24584549
N Engl J Med. 2015 Jul 16;373(3):232-42
pubmed: 26052984
J Endocrinol. 2018 Feb;236(2):69-84
pubmed: 29142025
Diabetes. 2014 Mar;63(3):1079-92
pubmed: 24296715
BMC Cardiovasc Disord. 2018 Apr 10;18(1):63
pubmed: 29636010
JAMA. 2015 Jul 7;314(1):52-60
pubmed: 26151266
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Eur J Heart Fail. 2018 Dec;20(12):1690-1700
pubmed: 30328645
Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006740
pubmed: 30354404
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Nat Commun. 2018 Apr 23;9(1):1602
pubmed: 29686402
Nat Rev Endocrinol. 2019 Oct;15(10):569-589
pubmed: 31439934
Int J Mol Med. 2018 Mar;41(3):1693-1703
pubmed: 29286061
Int J Biol Sci. 2019 Mar 10;15(5):1010-1019
pubmed: 31182921
Biochem Pharmacol. 2008 Dec 15;76(12):1637-43
pubmed: 18755155
Mayo Clin Proc. 2018 Apr;93(4):409-418
pubmed: 29545006
Cardiovasc Diabetol. 2019 Jul 30;18(1):96
pubmed: 31362743
Circulation. 2019 Sep 17;140(12):1004-1014
pubmed: 31362530
Diabetologia. 2004 Nov;47(11):1906-13
pubmed: 15565373
JACC Basic Transl Sci. 2018 Aug 26;3(5):575-587
pubmed: 30456329
Adv Ther. 2019 Jan;36(1):44-58
pubmed: 30465123
J Pharmacol Sci. 2015 Mar;127(3):260-74
pubmed: 25837922
Ann Med. 2017 Nov;49(7):552-561
pubmed: 28286967
Lancet Diabetes Endocrinol. 2019 Oct;7(10):741-743
pubmed: 31422061
Cardiovasc Res. 2014 Dec 1;104(3):423-31
pubmed: 25341892
Eur Heart J. 2020 Feb 14;41(7):882-889
pubmed: 31620788
Cell Physiol Biochem. 2019;53(5):865-886
pubmed: 31724838

Auteurs

Mario Schubert (M)

Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.

Sinah Hansen (S)

Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.

Julian Leefmann (J)

Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.

Kaomei Guan (K)

Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.

Classifications MeSH